oleanolic acid has been researched along with tamoxifen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, MM; El Diwani, HI; Galal, SA; Kerwin, SM; Li, J; Omar, MA; Ramadan, RA; Shaker, YM; Tokuda, H | 1 |
| Deng, Y; Li, CH; Wu, T; Zhai, SQ | 1 |
| Bukiya, AN; Dopico, AM; Liu, J; Toro, L | 1 |
| Andò, S; Barone, I; Bonofiglio, D; Catalano, S; Gelsomino, L; Giordano, C; Gu, G; Menichini, F; Statti, G | 1 |
1 review(s) available for oleanolic acid and tamoxifen
| Article | Year |
|---|---|
Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Female; Humans; Pregnancy; Toxoplasma; Toxoplasmosis | 2019 |
3 other study(ies) available for oleanolic acid and tamoxifen
| Article | Year |
|---|---|
Synthesis and docking studies of novel antitumor benzimidazoles.
Topics: Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Herpesvirus 4, Human; Humans; Lung Neoplasms; MCF-7 Cells; Models, Molecular; Pyrroles; Structure-Activity Relationship; Tetracyclines; Virus Activation | 2012 |
Beta1 (KCNMB1) subunits mediate lithocholate activation of large-conductance Ca2+-activated K+ channels and dilation in small, resistance-size arteries.
Topics: Animals; Calcium; Cerebral Arteries; Large-Conductance Calcium-Activated Potassium Channels; Lithocholic Acid; Male; Mice; Mice, Inbred C57BL; Oleanolic Acid; Protein Subunits; Rats; Rats, Sprague-Dawley; Saponins; Tamoxifen; Vascular Resistance; Vasodilation | 2007 |
Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulins; Oldenlandia; Oleanolic Acid; Plant Extracts; Promoter Regions, Genetic; Tamoxifen; Transcriptional Activation; Triterpenes; Tumor Suppressor Protein p53; Up-Regulation; Ursolic Acid | 2012 |